Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)